Clinical Trials Browser

Terminated × Breast Neoplasms × Atorvastatin × Clear all

NCT03872388 2024-10-02

Atorvastatin in Treating Patients With Stage IIb-III Triple Negative Breast Cancer Who Did Not Achieve a Pathologic Complete Response After Receiving Neoadjuvant Chemotherapy

Phase 2 Terminated

6 enrolled 8 charts

Breast Neoplasms, Inflammatory Breast Neoplasms, Triple Negative Breast Neoplasms

NCT02674204 2019-05-15

STOP

Phase 2 Terminated

2 enrolled 7 charts

Breast Neoplasms, Heart Diseases, Cardiotoxicity